首页> 美国政府科技报告 >In vitro Activity of Ciprofloxacin Compared to Trimethoprim-Sulfamethoxazole Against Campylobacter Spp., Shigella Spp. and Enterotoxigenic Escherichia Coli Causing Traveller's Diarrhea in Egypt
【24h】

In vitro Activity of Ciprofloxacin Compared to Trimethoprim-Sulfamethoxazole Against Campylobacter Spp., Shigella Spp. and Enterotoxigenic Escherichia Coli Causing Traveller's Diarrhea in Egypt

机译:环丙沙星与甲氧苄氨嘧啶 - 磺胺甲恶唑对抗弯曲杆菌,志贺氏菌的体外活性产肠毒素大肠埃希氏菌导致埃及旅行者腹泻

获取原文

摘要

The in vitro activity of ciprofloxacin against bacterial enteropathogens isolated from cases of travellers' diarrhea in Egypt was compared to trimethoprim (TMP) and trimethoprim-sulfamethoxazole (SXT). No resistance to ciprofloxacin was noted for any of the Campylobacter jejuni/coli, Shigella spp., and enterotoxigenic Escherichia coli strains examined. However, resistance to TMP and SXT was noted among these same strains. Because of its broad spectrum and lack of resistance, ciproflaxacin is potentially a useful drug for the treatment of diarrhea caused by bacterial enterophathogens encountered in this region of the world. Reprints. (kt)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号